Sugaya Yukiko, Yoshiba Takako, Kajima Takashi, Ishihama Yasushi
Department of Physical Chemistry, Analytical Research Laboratories, Eisai Co., Ltd., 5-1-3, Tokodai, Tsukuba, Ibaraki 300-2635, Japan.
Yakugaku Zasshi. 2002 Mar;122(3):237-46. doi: 10.1248/yakushi.122.237.
We developed two methods for solubility screening of drug candidates in drug discovery. The first is a solution-precipitation (SP) method, in which the sample solutions are prepared by adding the drug solution in dimethylsulfoxide (DMSO) to buffers followed by filtering off the precipitate using 96-well filterplate. The second is a powder-dissolution (PD) method, in which the solid samples are dissolved to the buffer in the HPLC vial equipped with the filter membrane in the HPLC autosampler. An HPLC equipped with a photodiode array detector is used to measure the concentration of the sample solutions in both methods. The SP method was used for high throughput screening the solvating process of the candidates in aqueous solutions with lower sample consumption, and the PD method was used for screening both inter-molecular interaction in solid state and solvation in aqueous solution with more sample amount than that of SP method. Therefore, the solubility screening from early to final stage of lead optimization process would be successfully accomplished by using both methods complementarily.
我们开发了两种用于药物研发中候选药物溶解度筛选的方法。第一种是溶液沉淀(SP)法,即通过将药物在二甲基亚砜(DMSO)中的溶液加入缓冲液中来制备样品溶液,然后使用96孔滤板滤去沉淀。第二种是粉末溶解(PD)法,即将固体样品在配备有HPLC自动进样器中滤膜的HPLC小瓶中溶解于缓冲液中。两种方法均使用配备光电二极管阵列检测器的HPLC来测量样品溶液的浓度。SP法用于高通量筛选候选药物在水溶液中的溶剂化过程,样品消耗量较低;PD法用于筛选固态下的分子间相互作用以及水溶液中的溶剂化作用,其样品量比SP法多。因此,通过互补使用这两种方法,可以成功完成从先导化合物优化过程的早期到最终阶段的溶解度筛选。